Dan Labach, Msc Email & Phone Number

My research in Dr. Stephen Barr’s laboratory focused on the prevention of viral infection and associated disease. I conducted research projects examining both human antiviral defenses and the preclinical development of antiviral therapeutics. In this role, I worked safely with infectious pathogens in a high-containment CL3 environment. As a senior.

I worked as an Intern with Bold Therapeutics through the Mitacs Accelerate program. Collaborating with the Preclinical Research department, I utilized cell culture and animal models of COVID-19 to evaluate the antiviral properties of the anticancer therapeutic BOLD-100. Based on this work, our team filed a patent application, and we are currently preparing.

As a Research Assistant in the Mobility Clinic, I supported the delivery of research programs and communicated findings to project stakeholders. In this role, I was responsible for liaising with clinicians and researchers, and developing posters, abstracts, and webinars for presentation at domestic and international spinal cord injury (SCI) conferences. I.

Kitchener, Ontario, Canada

Master Of Science - Msc, Microbiology And Immunology

Cumulative GPA: 4.0/4.0 Thesis Title: "In Vitro and In Vivo Characterization of the Metallodrug BOLD-100 as an Inhibitor of SARS-CoV-2.

Bachelor Of Medical Sciences - Bmsc, Microbiology And Immunology

Cumulative GPA: 3.98/4.0 Honours Specialization in Microbiology and Immunology, Minor in French Studies